Single Dose Escalation Study of GSK2838232 in Healthy Subjects

NCT01802918 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG: GSK2838232
DRUG: Placebo
DRUG: Ritonavir

Sponsor

GlaxoSmithKline